Good Afternoon! 

Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news.

Happy Monday! It’s November 27th. I hope you had a great weekend.

🔥  Our blowout Black Friday deal on Elite Growth Stocks is still live! We got a great response so we’re extending it one last time for Cyber Monday. Claim your discount by midnight ET tonight to or you could miss out.

Now, let's get ready to trade!

Brought to You By

Harness The Economist's approach to business writing

How do you write persuasively for business? Study the psychology, craft and purpose of writing with experts from The Economist.

The six-week Professional Communication: Business Writing and Storytelling online short course from The Economist is designed to help business professionals attract and address broad audiences across various written formats. 

On completion of this course, you’ll walk away with:

• Practical writing, editing and data-visualisation skills for creating clear and compelling business communications.

• A writer’s toolkit based on The Economist’s editorial approach, helping you to navigate questions of structure, word choice and style.

• The ability to source, structure and convey information in a way that is accurate, engaging and ethical.

Markets 📈

Stocks closed Friday’s half-day session with mixed results. The Dow added 0.3%, while the S&P 500 added less than 0.1%. The Nasdaq ended the day down 0.1%, and the small-cap Russell 2K outperformed with a 0.6% advance.

Futures are down in early trading. S&P 500 contracts are showing a 0.1% decline.

Premarket Highlights 🔎

🕊 None

It’s been a quiet start to the trading day. Everyone is still waking up from their holiday slumber. I expect a rather tame trading session today.

What to Watch Today 🔍

New Home Sales

Today’s calendar doesn’t have any major events that catch my eye, but the New Home Sales report could be worth a peek. High mortgage rates and plummeting inventories have strangled the home buying market, but prices remain elevated in many areas. This report could provide some valuable insights in an otherwise uneventful trading day.

Featured Earnings 💲

• UP Fintech Holding Limited [TIGR] ... AM

• Cerence [CRNC] ... AM

• Anavex Life Sciences [AVXL] ... AM

• Smart Share Global Limited [EM] ... AM

• Zscaler [ZS] ... PM

• Cango [CANG] ... PM

Economy 🏗

• New home sales [Oct] ... 10:00a

Gainers

• Mobiquity Tech [MOBQ] >> +32.6%

• Ambow Education [AMBO] >> +20.2%

• Capitvision [CAPT] >> +11.5%

Decliners

• Conifer Holdings [CNFR] >> (31.0%)

• BioNexus Gene Lab [BGLC] >> (24.3%)

• Impel Neuropharma [IMPL] >> (27.0%)

Crown Castle [CCI] - Last Close: $103.58

Activist investors have their sights on Crown Castle.

This morning, a WSJ report claimes Elliott Management had amassed a $2 billion stake in CCI in an effort to force change at the wireless tower operator.

Elliott made a similar attempt in the past with Crown Castle, but the effort produced limited success.

Now, the activist hedge fund wants to engage with Crown Castle and explore strategies for improving the performance of its shares.

In the past, Elliott has criticized Crown Castle’s fiber strategy as “undisciplined” and called on management to focus on higher-return opportunities.

CCI is leading the S&P 500 with a 4.9% gain on news of the activist renewed investor’s interest in the company.

Apollomics [APLM] - Last Close: $0.9972

Apollomics is extending its hot streak.

The tiny biotech firm has been on a tear since last week, when HC Wainwright analysts maintained a $17 price target and reiterated their “buy” rating.

The bullish analyst note came shortly after Apollomics partner in China, Avistone Biotechnology, got conditional approval for commercialization of vebreltinib.

Since then, shares have been on a tear. As of Friday’s close, APLM was up 74.9% over the past 30 days, and it’s running hot again today.

APLM is one of this morning’s top performers with a 30.3% gain on elevated trading volume.

RedHill Biopharma [RDHL] - Last Close: $0.3155

RedHill Bio is rallying on a regulatory ruling.

This morning, the company said the FDA granted it a 5-year U.S. market exclusivity for Talicia® under a special approval for antibiotics.

The FDA’s ruling will extend RedHill intellectual property protection on on the drug until 2034.

Talicia is a first-line antibiotic for U.S. gastroenterologists treating H. pylori - a bacterial infection that affects approximately 35% of the U.S. adult population.

RDHL is a top performer today with a 153.2% gain on elevated volume.

Near Intelligence [NIR] - Last Close: $0.1482

Near Intelligence is rebounding after a recent slide.

Shares of the stock began selling off on Tuesday of last week, when the company announced the termination of its CEO, Rahul Agarwal, effective immediately.

Near Intelligence also took a hit when it missed its 10-Q quarterly financials filing deadline shortly before announcing the firing its CEO.

Altogther, NIR is down 21.9% over the past 10 days, but the drawdown may have been overdone because shares are suddenly rebounding today.

NIR is one of this morning’s top stocks with a 30.8% gain on elevated trading volume.

That's it for today! Thanks for reading, and good luck out there!

Best Regards,

— Chris D.
Elite Trade Club

Text ELITE to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.